omniture

Frost & Sullivan Applauds Inspirata's Leading-edge Digital Pathology Solutions that Accelerate Cancer Diagnostics, Monitoring, Treatment, and Surveillance

Inspirata's full set of digital pathology technologies enables the digitization, automation, and interoperability of the entire pathology workflow
Frost & Sullivan
2016-12-13 21:00 1762

MOUNTAIN VIEW, Calif., Dec. 13, 2016 /PRNewswire/ -- Based on its recent analysis of the digital pathology and cancer diagnostics market, Frost & Sullivan recognizes Inspirata® with the 2016 North American Frost & Sullivan Award for Technology Leadership. Inspirata's groundbreaking digital pathology solution greatly lowers the time and costs involved in cancer diagnostics by automating the entire pathology workflow as a managed service. It achieves this by using digital images and leveraging its integrated Digital Pathology Cockpit, novel image analysis algorithms, and prognostic and predictive assays.

Inspirata, Inc. Receives 2016 North American Digital Pathology and Cancer Diagnostics Technology Innovation Award
Inspirata, Inc. Receives 2016 North American Digital Pathology and Cancer Diagnostics Technology Innovation Award

Click here to read the Frost & Sullivan Award Write Up

Inspirata not only optimizes the workflow but also extracts relevant image-based information from digitized histology tissue specimens to gain deeper insights into cancer, its progression, and treatment. Furthermore, the company plans to stimulate innovation-driven product development through a large-scale cancer information database that can be used for research and educational activities as well as clinical endeavors.

Inspirata developed a flexible and scalable platform that lowers the complexities of multiple points of contact between systems. Its enterprise service bus (ESB) connects seamlessly with institution-maintained integration engines or directly with its existing systems. Systems that the ESB can communicate with include anatomic pathology laboratory information system (APLIS), electronic medical records (EMR), radiology application data (RAD), grossing and endoscopy imaging systems (ENDO), as well as molecular and -omics technology systems.

Another important component of its diagnostic solution is the Digital Pathology Cockpit. It is a specially designed desktop system with either two- or three-monitor configurations that provide single sign-on access to the patient's history, clinical notes and other diagnostic imaging modalities. The cockpit enables pathologists to review cases more comprehensively and efficiently than with the traditional microscope.

"PathologyNEXT® embodies Inspirata's overall approach to transforming the pathology workflow from analog to digital," said Frost & Sullivan Industry Analyst and Associate Fellow Cecilia Van Cauwenberghe. "It comprises round-the-clock, high-volume, high-speed slide scanning services and the integrated Digital Pathology Cockpit used for image viewing, image sharing, annotation, image analysis, and reporting."

Inspirata's suite of digital pathology algorithms is used to detect unusual cell structures and other morphological abnormalities in a pre-screening process known as Informed Detection. This application serves to triage the case list and assist the pathologist to quickly identify potential malignancies. Another novel image analysis algorithm, the MitoSEK™, allows pathologies to highlight a single feature and use the algorithm to find all similar features in the same image, eliminating the need for a time-consuming manual identification and counting process.

"By moving the solution from a CAPEX model to an OPEX model, Inspirata's software-as-a-solution model is reshaping the North American healthcare sector," noted Van Cauwenberghe. "The bundling of digital pathology hardware, software and the associated infrastructure makes this a complete solution."

For revolutionizing the North American industry with a set of services supporting its digital pathology and cancer diagnostics solutions, Frost & Sullivan is pleased to present Inspirata with the 2016 North American Frost & Sullivan Award for Technology Leadership.

Each year, Frost & Sullivan presents the Technology Leadership award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the large R&D spend towards innovation, its relevance to the industry, and the positive impact on brand perception.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Inspirata, Inc.

Inspirata®, Inc. offers the most comprehensive Cancer Diagnostics Workflow Solution available for research and precision diagnosis today. The solution, which employs a unique "solution-as-a-service" delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data repository for clinical, research and educational purposes. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact info@inspirata.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Contact us: Start the discussion.

Contact:

Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003
E: chiara.carella@frost.com

Photo - http://photos.prnasia.com/prnh/20161207/8521607998


Source: Frost & Sullivan
Related Links:
collection